Which statement correctly defines a rebate in pharmaceutical distribution?

Which statement correctly defines a rebate in pharmaceutical distribution?

• A. The upfront discount offered to a hospital at the time of purchase.
• B. The amount the drug manufacturer pays to a health plan for each unit dispensed.
• C. A fee charged by wholesalers to retailers for storage.
• D. The amount paid by patients as a copay for a prescribed drug.

Answer: (B)

Rebates are payments made after a sale by the manufacturer to a payer (such as a health plan or PBM) to reduce the net price of a drug. They’re tied to formulary placement or volume and aim to secure preferred access rather than being an upfront discount at purchase. The option describing a per-unit payment from the manufacturer to the health plan captures this post-sale price concession mechanism. It explains how rebates influence the payer’s overall cost and market access. Upfront discounts, storage fees, and patient copays reflect different concepts (initial price reductions, charges for distribution services, and patient out-of-pocket costs, respectively) and do not describe rebates.

Rebates are payments made after a sale by the manufacturer to a payer (such as a health plan or PBM) to reduce the net price of a drug. They’re tied to formulary placement or volume and aim to secure preferred access rather than being an upfront discount at purchase.

The option describing a per-unit payment from the manufacturer to the health plan captures this post-sale price concession mechanism. It explains how rebates influence the payer’s overall cost and market access.

Upfront discounts, storage fees, and patient copays reflect different concepts (initial price reductions, charges for distribution services, and patient out-of-pocket costs, respectively) and do not describe rebates.